We looked at September to see which names pick up the most Analyst upgrades and which names had the most Analyst downgrades. Fast Retailing Co Ltd...
Kyowa Hakko Kirin's (4151 JP) announcement that “moga” – mogamulizumab (KW-0761) – has met its primary endpoint (PFS) in Phase III trials for...
Legislation and regulation in Japan tend to be evolutionary rather than revolutionary. You get the odd inflection point coming out of nowhere – the...